Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire: How Outdated Imaging Equipment is Impacting Quality of Care and Claim Costs
In workers’ compensation, diagnostic imaging – such as an MRI, CT, or PET scan – is often the first critical step to assess the severity of a
Average Length of Rental for Repairable Vehicles: Q4 2018
The quarterly LOR summary is produced by
5G: What High-Flying Predictions Mean for the Property & Casualty and Collision Repair Industries
Today’s technology news is dominated by articles about the promise of 5G, and with 5G set to roll out even more broadly in 2020, the impact that it
Premiums Written: Q1 2019 Casualty Must-Reads
Each quarter, I round up and highlight some of my favorite articles written by Mitchell experts and let you know where we have been published outsi
OEM Efforts to Promote Environmental Stewardship
According to the Environmental Protection Agency (EPA), transportation contributes 27% of all greenhouse gas emissions in the United States.1
Current Used Vehicle Market Conditions: Q4 2018
December 2018 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytica